This inventor holds 2 USPTO granted patents. Top assignees: Department of Health the Executive Yuan, Republic of China, Standard Chemical & Pharmaceutical Co., Ltd.. Active years: 1996-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 1996-1997
Title: Innovations of Jia-Shuai Lee in Pharmaceutical Chemistry
Introduction
Jia-Shuai Lee is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of Parkinson's disease. With a total of 2 patents, his work showcases innovative approaches to drug delivery and synthesis.
Latest Patents
One of Jia-Shuai Lee's latest patents involves the creation of di- and tri-peptide mimetic compounds for Parkinson's disease. This series of compounds includes D-phenylglycine or D-p-hydroxyphenylglycine, which serve as tools for delivering L-dopa through the intestine via the intestinal dipeptide-mediated carrier transport system. These compounds are recognized for their potential as active ingredients in treating Parkinson's disease. Another significant patent is a method for preparing cephalosporin derivatives. This method involves reacting cephalosporin alkaline metal salts with organic halides in the presence of quaternary ammonium salts as catalysts. Notably, the side reaction of .DELTA..sup.3 .fwdarw..DELTA..sup.2 isomerization, commonly reported in the preparation of cephalosporin derivatives, was successfully eliminated, resulting in the desired .DELTA..sup.3 as the sole product.
Career Highlights
Jia-Shuai Lee has worked with the Department of Health, the Executive Yuan, Republic of China, and Standard Chemical & Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Throughout his career, Jia-Shuai Lee has collaborated with notable colleagues, including Hui-po Wang and Hsiao-Hwa Lu. These partnerships have likely enhanced his research and development efforts.
Conclusion
Jia-Shuai Lee's contributions to pharmaceutical chemistry, particularly in the treatment of Parkinson's disease and cephalosporin derivatives, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile